IBDEI2YN ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,47248,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47248,1,3,0)
;;=3^Opioid Use,Unspec,Uncomplicated
;;^UTILITY(U,$J,358.3,47248,1,4,0)
;;=4^F11.90
;;^UTILITY(U,$J,358.3,47248,2)
;;=^5003142
;;^UTILITY(U,$J,358.3,47249,0)
;;=Z79.891^^181^2359^1
;;^UTILITY(U,$J,358.3,47249,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47249,1,3,0)
;;=3^Long Term Opiate/Opioid Analgesic Use
;;^UTILITY(U,$J,358.3,47249,1,4,0)
;;=4^Z79.891
;;^UTILITY(U,$J,358.3,47249,2)
;;=^5063342
;;^UTILITY(U,$J,358.3,47250,0)
;;=M15.8^^181^2360^51
;;^UTILITY(U,$J,358.3,47250,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47250,1,3,0)
;;=3^Polyosteoarthritis,Other
;;^UTILITY(U,$J,358.3,47250,1,4,0)
;;=4^M15.8
;;^UTILITY(U,$J,358.3,47250,2)
;;=^5010767
;;^UTILITY(U,$J,358.3,47251,0)
;;=F07.0^^181^2360^41
;;^UTILITY(U,$J,358.3,47251,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47251,1,3,0)
;;=3^Personality Change d/t Physiological Condition
;;^UTILITY(U,$J,358.3,47251,1,4,0)
;;=4^F07.0
;;^UTILITY(U,$J,358.3,47251,2)
;;=^5003063
;;^UTILITY(U,$J,358.3,47252,0)
;;=G62.9^^181^2360^50
;;^UTILITY(U,$J,358.3,47252,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47252,1,3,0)
;;=3^Polyneuropathy,Unspec
;;^UTILITY(U,$J,358.3,47252,1,4,0)
;;=4^G62.9
;;^UTILITY(U,$J,358.3,47252,2)
;;=^5004079
;;^UTILITY(U,$J,358.3,47253,0)
;;=F43.10^^181^2360^1
;;^UTILITY(U,$J,358.3,47253,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47253,1,3,0)
;;=3^PTSD Unspec
;;^UTILITY(U,$J,358.3,47253,1,4,0)
;;=4^F43.10
;;^UTILITY(U,$J,358.3,47253,2)
;;=^5003570
;;^UTILITY(U,$J,358.3,47254,0)
;;=F43.12^^181^2360^2
;;^UTILITY(U,$J,358.3,47254,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47254,1,3,0)
;;=3^PTSD,Chr
;;^UTILITY(U,$J,358.3,47254,1,4,0)
;;=4^F43.12
;;^UTILITY(U,$J,358.3,47254,2)
;;=^5003572
;;^UTILITY(U,$J,358.3,47255,0)
;;=G20.^^181^2360^39
;;^UTILITY(U,$J,358.3,47255,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47255,1,3,0)
;;=3^Parkinson's Disease
;;^UTILITY(U,$J,358.3,47255,1,4,0)
;;=4^G20.
;;^UTILITY(U,$J,358.3,47255,2)
;;=^5003770
;;^UTILITY(U,$J,358.3,47256,0)
;;=I73.9^^181^2360^3
;;^UTILITY(U,$J,358.3,47256,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47256,1,3,0)
;;=3^PVD,Unspecified
;;^UTILITY(U,$J,358.3,47256,1,4,0)
;;=4^I73.9
;;^UTILITY(U,$J,358.3,47256,2)
;;=^184182
;;^UTILITY(U,$J,358.3,47257,0)
;;=I80.3^^181^2360^46
;;^UTILITY(U,$J,358.3,47257,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47257,1,3,0)
;;=3^Phlebitis & Thrombophlebitis Lower Extremities,Unspec
;;^UTILITY(U,$J,358.3,47257,1,4,0)
;;=4^I80.3
;;^UTILITY(U,$J,358.3,47257,2)
;;=^5007845
;;^UTILITY(U,$J,358.3,47258,0)
;;=J02.9^^181^2360^42
;;^UTILITY(U,$J,358.3,47258,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47258,1,3,0)
;;=3^Pharyngitis Acute,Unspec
;;^UTILITY(U,$J,358.3,47258,1,4,0)
;;=4^J02.9
;;^UTILITY(U,$J,358.3,47258,2)
;;=^5008130
;;^UTILITY(U,$J,358.3,47259,0)
;;=J18.9^^181^2360^49
;;^UTILITY(U,$J,358.3,47259,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47259,1,3,0)
;;=3^Pneumonia,Unspec Organism
;;^UTILITY(U,$J,358.3,47259,1,4,0)
;;=4^J18.9
;;^UTILITY(U,$J,358.3,47259,2)
;;=^95632
;;^UTILITY(U,$J,358.3,47260,0)
;;=R09.1^^181^2360^48
;;^UTILITY(U,$J,358.3,47260,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47260,1,3,0)
;;=3^Pleurisy
;;^UTILITY(U,$J,358.3,47260,1,4,0)
;;=4^R09.1
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2YN 3763 printed Oct 16, 2024@18:39:10 Page 2
IBDEI2YN ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,47248,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,47248,1,3,0)
+4 ;;=3^Opioid Use,Unspec,Uncomplicated
+5 ;;^UTILITY(U,$J,358.3,47248,1,4,0)
+6 ;;=4^F11.90
+7 ;;^UTILITY(U,$J,358.3,47248,2)
+8 ;;=^5003142
+9 ;;^UTILITY(U,$J,358.3,47249,0)
+10 ;;=Z79.891^^181^2359^1
+11 ;;^UTILITY(U,$J,358.3,47249,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,47249,1,3,0)
+14 ;;=3^Long Term Opiate/Opioid Analgesic Use
+15 ;;^UTILITY(U,$J,358.3,47249,1,4,0)
+16 ;;=4^Z79.891
+17 ;;^UTILITY(U,$J,358.3,47249,2)
+18 ;;=^5063342
+19 ;;^UTILITY(U,$J,358.3,47250,0)
+20 ;;=M15.8^^181^2360^51
+21 ;;^UTILITY(U,$J,358.3,47250,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,47250,1,3,0)
+24 ;;=3^Polyosteoarthritis,Other
+25 ;;^UTILITY(U,$J,358.3,47250,1,4,0)
+26 ;;=4^M15.8
+27 ;;^UTILITY(U,$J,358.3,47250,2)
+28 ;;=^5010767
+29 ;;^UTILITY(U,$J,358.3,47251,0)
+30 ;;=F07.0^^181^2360^41
+31 ;;^UTILITY(U,$J,358.3,47251,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,47251,1,3,0)
+34 ;;=3^Personality Change d/t Physiological Condition
+35 ;;^UTILITY(U,$J,358.3,47251,1,4,0)
+36 ;;=4^F07.0
+37 ;;^UTILITY(U,$J,358.3,47251,2)
+38 ;;=^5003063
+39 ;;^UTILITY(U,$J,358.3,47252,0)
+40 ;;=G62.9^^181^2360^50
+41 ;;^UTILITY(U,$J,358.3,47252,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,47252,1,3,0)
+44 ;;=3^Polyneuropathy,Unspec
+45 ;;^UTILITY(U,$J,358.3,47252,1,4,0)
+46 ;;=4^G62.9
+47 ;;^UTILITY(U,$J,358.3,47252,2)
+48 ;;=^5004079
+49 ;;^UTILITY(U,$J,358.3,47253,0)
+50 ;;=F43.10^^181^2360^1
+51 ;;^UTILITY(U,$J,358.3,47253,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,47253,1,3,0)
+54 ;;=3^PTSD Unspec
+55 ;;^UTILITY(U,$J,358.3,47253,1,4,0)
+56 ;;=4^F43.10
+57 ;;^UTILITY(U,$J,358.3,47253,2)
+58 ;;=^5003570
+59 ;;^UTILITY(U,$J,358.3,47254,0)
+60 ;;=F43.12^^181^2360^2
+61 ;;^UTILITY(U,$J,358.3,47254,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,47254,1,3,0)
+64 ;;=3^PTSD,Chr
+65 ;;^UTILITY(U,$J,358.3,47254,1,4,0)
+66 ;;=4^F43.12
+67 ;;^UTILITY(U,$J,358.3,47254,2)
+68 ;;=^5003572
+69 ;;^UTILITY(U,$J,358.3,47255,0)
+70 ;;=G20.^^181^2360^39
+71 ;;^UTILITY(U,$J,358.3,47255,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,47255,1,3,0)
+74 ;;=3^Parkinson's Disease
+75 ;;^UTILITY(U,$J,358.3,47255,1,4,0)
+76 ;;=4^G20.
+77 ;;^UTILITY(U,$J,358.3,47255,2)
+78 ;;=^5003770
+79 ;;^UTILITY(U,$J,358.3,47256,0)
+80 ;;=I73.9^^181^2360^3
+81 ;;^UTILITY(U,$J,358.3,47256,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,47256,1,3,0)
+84 ;;=3^PVD,Unspecified
+85 ;;^UTILITY(U,$J,358.3,47256,1,4,0)
+86 ;;=4^I73.9
+87 ;;^UTILITY(U,$J,358.3,47256,2)
+88 ;;=^184182
+89 ;;^UTILITY(U,$J,358.3,47257,0)
+90 ;;=I80.3^^181^2360^46
+91 ;;^UTILITY(U,$J,358.3,47257,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,47257,1,3,0)
+94 ;;=3^Phlebitis & Thrombophlebitis Lower Extremities,Unspec
+95 ;;^UTILITY(U,$J,358.3,47257,1,4,0)
+96 ;;=4^I80.3
+97 ;;^UTILITY(U,$J,358.3,47257,2)
+98 ;;=^5007845
+99 ;;^UTILITY(U,$J,358.3,47258,0)
+100 ;;=J02.9^^181^2360^42
+101 ;;^UTILITY(U,$J,358.3,47258,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,47258,1,3,0)
+104 ;;=3^Pharyngitis Acute,Unspec
+105 ;;^UTILITY(U,$J,358.3,47258,1,4,0)
+106 ;;=4^J02.9
+107 ;;^UTILITY(U,$J,358.3,47258,2)
+108 ;;=^5008130
+109 ;;^UTILITY(U,$J,358.3,47259,0)
+110 ;;=J18.9^^181^2360^49
+111 ;;^UTILITY(U,$J,358.3,47259,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,47259,1,3,0)
+114 ;;=3^Pneumonia,Unspec Organism
+115 ;;^UTILITY(U,$J,358.3,47259,1,4,0)
+116 ;;=4^J18.9
+117 ;;^UTILITY(U,$J,358.3,47259,2)
+118 ;;=^95632
+119 ;;^UTILITY(U,$J,358.3,47260,0)
+120 ;;=R09.1^^181^2360^48
+121 ;;^UTILITY(U,$J,358.3,47260,1,0)
+122 ;;=^358.31IA^4^2
+123 ;;^UTILITY(U,$J,358.3,47260,1,3,0)
+124 ;;=3^Pleurisy
+125 ;;^UTILITY(U,$J,358.3,47260,1,4,0)
+126 ;;=4^R09.1
